View Future GrowthBluGlass 과거 순이익 실적과거 기준 점검 0/6BluGlass 의 수입은 연평균 -9%의 비율로 감소해 온 반면, Semiconductor 산업은 연평균 3.6%의 비율로 증가했습니다. 매출은 연평균 55.8%의 비율로 증가해 왔습니다.핵심 정보-9.03%순이익 성장률13.04%주당순이익(EPS) 성장률Semiconductor 산업 성장률27.66%매출 성장률55.75%자기자본이익률-130.81%순이익률-159.60%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listing공시 • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing공시 • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia공시 • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Options공시 • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australia공시 • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074공시 • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing공시 • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing공시 • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.공시 • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.공시 • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.공시 • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.매출 및 비용 세부 내역BluGlass가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:BUGL.F 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Dec 256-913030 Sep 256-1013030 Jun 255-1113031 Mar 256-1112031 Dec 246-1012030 Sep 245-1012030 Jun 245-1011031 Mar 243-1111031 Dec 232-1211030 Sep 231-1210030 Jun 231-1210031 Mar 231-119031 Dec 221-108030 Sep 221-107030 Jun 221-96031 Mar 220-85031 Dec 210-74030 Sep 210-74030 Jun 210-64031 Mar 210-65031 Dec 200-75030 Sep 201-65030 Jun 201-66031 Mar 201-106031 Dec 191-156030 Sep 191-155030 Jun 190-145031 Mar 191-105031 Dec 181-55-130 Sep 181-44030 Jun 181-44031 Mar 181-44031 Dec 171-44030 Sep 171-44030 Jun 171-44031 Mar 170-44031 Dec 16-1-44030 Sep 160-44030 Jun 160-34031 Mar 160-34031 Dec 150-34030 Sep 150-340양질의 수익: BUGL.F 은(는) 현재 수익성이 없습니다.이익 마진 증가: BUGL.F는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: BUGL.F은 수익성이 없으며 지난 5년 동안 손실이 연평균 9% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 BUGL.F의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: BUGL.F은 수익성이 없어 지난 해 수익 성장률을 Semiconductor 업계(22.6%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: BUGL.F는 현재 수익성이 없으므로 자본 수익률이 음수(-130.81%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSemiconductors 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/08 02:28종가2026/07/06 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스BluGlass Limited는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Mark BryanCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.Darren VincentShaw and Partners Limited
공시 • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listing
공시 • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
공시 • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia
공시 • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Options
공시 • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australia
공시 • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074
공시 • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
공시 • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
공시 • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.
공시 • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.
공시 • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.
공시 • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.